newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022

BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS)